KZR — Kezar Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Kezar Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	208	277	201	132	71.9
Net Total Receivables	0.07	—	2.29	0.424	1.93
Prepaid Expenses
Total Other Current Assets
Total Current Assets	212	286	207	137	75.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6	13.2	8.69	4.78	0.915
Other Long Term Assets
Total Assets	218	300	221	145	76.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.21	11	17.7	20.3	6.57
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.1	29.7	33.7	27.8	6.57
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	197	270	188	117	70.1
Total Liabilities & Shareholders' Equity	218	300	221	145	76.6
Total Common Shares Outstanding